Adults with Loeys–Dietz syndrome and vascular Ehlers–Danlos syndrome: A cross‐sectional study of health burden perspectives
Authors:
- 6 November 2019
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 182 (1) , 137-145
Abstract
The aim is to study adults with vascular Ehlers–Danlos syndrome (vEDS) and Loeys–Dietz syndrome (LDS) with regard to sociodemographic characteristics, perceived vascular‐ and multi‐organ symptom burdens, and health services utilization. This is a cross‐sectional study. In 2018, a postal questionnaire was sent to 71 individuals with genetically verified LDS types 1–4 or vEDS, age ≥ 18 years, recruited through a National Resource Centre for Rare Disorders in Norway. Eighteen patients with vEDS and 34 patients with LDS subtypes 1‐4 participated, the response rate was 74%. Median age was 43.5 (range 18‐68) years, and 58% were women. Median age at diagnosis was 34 years (range: 6–63). Severe vascular‐ and multi‐organ symptom burdens were found, and chronic pain was reported by 79%. Most respondents (87%) had cardiovascular surveillance visits, 58% yearly or more often, and still 29% had no antihypertensive medications. Three quarters communicated diagnosis‐related concerns with their general practitioner. A considerable group (31%) had left work before retirement age. Healthcare professionals should be aware of the spectrum of health burden in adults with vEDS and LDS. A verification of the diagnosis is crucial to counseling, including medical follow‐up, education, and work, and advices on precaution and life style decisions.Keywords
This publication has 25 references indexed in Scilit:
- Survival is affected by mutation type and molecular mechanism in vascular Ehlers–Danlos syndrome (EDS type IV)Genetics in Medicine, 2014
- Health-related quality of life in Marfan syndrome: A cross-sectional study of Short Form 36 in 84 adults with a verified diagnosisGenetics in Medicine, 2010
- Prevalence data on all Ghent features in a cross-sectional study of 87 adults with proven Marfan syndromeEuropean Journal of Human Genetics, 2009
- Age and the Experience of Chronic PainThe Clinical Journal of Pain, 2005
- Living with Marfan syndrome: coping with stigmaClinical Genetics, 2005
- A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2Nature Genetics, 2005
- CONSORT statement: extension to cluster randomised trialsBMJ, 2004
- Prevalence of subjective health complaints (SHC) in NorwayScandinavian Journal of Public Health, 2002
- Standardised Nordic questionnaires for the analysis of musculoskeletal symptomsApplied Ergonomics, 1987
- Patients with Ehlers-Danlos syndrome type IV lack type III collagen.Proceedings of the National Academy of Sciences, 1975